https://www.selleckchem.com/pr....oducts/avelestat-azd
Our previous work demonstrated that 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine ( F-DOPA) positron emission tomography (PET) is sensitive and specific for identifying regions of high density and biologically aggressive glioblastoma. The purpose of this prospective phase 2 study was to determine the safety and efficacy of biologic-guided, dose-escalated radiation therapy (DERT) using F-DOPA PET in patients with glioblastoma. Patients with newly diagnosed, histologically confirmed glioblastoma aged ≥18 years without contraindic
Like
Comment
Share
